SBI Securities’s BioLineRX BLRX Stock Holding History

SBI Securities’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$24	Hold	10	–	–	﹤0.01%	3886
2026 Q2	$31	Buy	+10	New	+$29	﹤0.01%	3766
2025 Q4	–	Sell	-2	Closed	-$8	–	4044
2025 Q3	$8	Hold	2	–	–	﹤0.01%	4059
2025 Q2	$9	Hold	2	–	–	﹤0.01%	4019
2025 Q1	$6	Sell	2 -76	-97%	-$306	﹤0.01%	4011
2024 Q4	$664	Buy	+78	New	+$1.15K	﹤0.01%	2790

Other funds holding BLRX

Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Nemes Rush Group Novi, Michigan $1.22B AUM 25.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

SBI Securities's BLRX Position: Q3 2026 in Review

SBI Securities held its BioLineRX (BLRX) position steady in Q3 2026 at 10 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #3886.

SBI Securities first reported a position in BLRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $664 in Q4 2024. 9 funds tracked by Wall St. Rank hold BLRX as of Q3 2026.

SBI Securities held 10 shares of BioLineRX worth $24 as of Q3 2026.
SBI Securities left its BioLineRX share count unchanged in Q3 2026.
BioLineRX made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3886 holding.
SBI Securities first reported a position in BioLineRX in Q4 2024 and has held it in 6 quarters since.
SBI Securities's BioLineRX position peaked at $664 in Q4 2024.
9 funds tracked by Wall St. Rank held BioLineRX as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.